BS29 Single cell transcriptomics reveals regenerative embryonic pathways lost in the adult epicardium. (4th June 2021)

• Record Type: Journal Article
• Authors: Knight-Schrijver, Vincent; Gambardella, Laure; Davaapil, Hongorzul; Sinha, Sanjay; Ross, Alexander; Vallier, Ludovic
• Is Part Of: Heart. Volume 107(2021)Supplement 1
• Page Start: A172
• Page End: A172
• Publication Date: 2021-06-04
• Subjects: Heart regeneration -- Epicardium -- Bioinformatics; Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/heartjnl-2021-BCS.227
• Languages: English
• ISSNs: 1355-6037

Abstract

Abstract : Background: Damage to the heart muscle often leads to chronic arrhythmia and heart failure. This is because the muscle of the adult human heart does not functionally regenerate after injury and is replaced by fibrous non-contractile and non-conductive scar tissue. However, the heart muscle of some vertebrates and developing mammals is capable of regeneration which restores the muscular function of the damaged tissue. Evidence suggests that the epicardium plays a crucial role in orchestrating this successful regenerative response in animals like the zebrafish and that epicardium cells are active in developmental stages of life. However, in adult humans the epicardium is putatively quiescent. Objectives: We hypothesise that the difference in the regenerative capacity of human adult and foetal myocardium may be explained in part by differences in the epicardium and reactivation of these molecular processes lost in adult epicardium may lead to effective myocardial regeneration. Using single-cell RNA sequencing, our aim was to capture the regenerative epicardial signalling present in the foetal epicardium that may be absent in adult hearts. Methods: Heart sections from 7 human embryos between 8 and 12 weeks of gestation were dissociated and sequenced with scRNA-seq. ScRNA-seq data from 5 human adult hearts between 55 and 75 years old were acquired from the Heart Cell Atlas. Data were integrated and epicardial cells in all samples were identified using supervised classification and canonical markers. Results: We compared the markers expressed in foetal and adult mesothelial epicardial cells and identified foetal, adult and stage-independent epicardial signatures. Among these were a number of pro-angiogenic factors specific to the foetal epicardium, including a group of WNT-signalling secreted factors, WNT2B, SFRP2 and SFRP5. Gene Ontology suggested a shift towards immune response of the epicardial cells during maturation. Additionally, an epicardial cluster with fibroblast-like markers was found only in the foetal heart (96 % foetal). We examined organ-wide influences of epicardial signalling by mapping the potential ligand receptor interactions from the epicardial-derived secreted factors to receptors upregulated in other heart cell clusters. This revealed the prospective influence of reactivating foetal epicardial pathways for heart regeneration. Lastly, we demonstrated that epicardium derived from human embryonic stem cells exhibits some of these lost regenerative pathways, promoting their value as a model and as therapeutic agents. Conclusions: We have shown that the adult epicardium has major differences to the foetal epicardium. Firstly, a set of epicardium-specific angiogenic pathways are absent from the adult epicardium and secondly, foetal hearts contain another epicardial cell type that is not present in the adult heart. Recapitulating both the missing epicardial signals and the synergy between the foetal epicardial cell types may be essential for developing effective regenerative stem cell therapy. Conflict of Interest: None